The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy. Academic Article uri icon

Overview

abstract

  • Fifty-eight patients with orbital rhabdomyosarcoma were treated with irradiation alone (25) or irradiation and chemotherapy (33) with follow-ups of 6 months to 14 years (mean 5.2 yr). At present, 74% are alive and 26% have died. Local control of the tumor was accomplished in 91% of cases. When local sinuses were invaded the survival rate was 55%. Chemotherapy appears to be of greatest value when disease is limited to the orbit. Irradiation or irradiation and chemotherapy should now be the treatment of choice for orbital rhabdomyosarcoma.

publication date

  • July 1, 1979

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasm Recurrence, Local
  • Orbital Neoplasms
  • Rhabdomyosarcoma

Identity

Scopus Document Identifier

  • 0018492692

PubMed ID

  • 233865

Additional Document Info

volume

  • 86

issue

  • 7